To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy

NCT06940336 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Transthyretin Amyloid Polyneuropathy

Interventions

DRUG: Tafamidis Meglumine Soft Capsules

Sponsor

Qilu Pharmaceutical Co., Ltd.